Immune Checkpoint Therapy Approved for Non-metastatic Melanoma After Surgery
The FDA approved nivolumab for some patients with melanoma whose tumor was completely removed through surgery and has not...
Progress Against Cancer
The FDA approved nivolumab for some patients with melanoma whose tumor was completely removed through surgery and has not...
The FDA approved encorafenib with binimetinib as a treatment for certain patients with non-small cell lung cancer. The U.S....
A targeted therapy previously approved for adults is now available for certain pediatric patients with blood cancer. The U.S....
The FDA Project Renewal initiative has updated the approved indications for temozolomide chemotherapy in anaplastic astrocytoma. The U.S. Food...
The FDA approved a kit that allows for liver-directed delivery of the chemotherapy melphalan to treat metastatic liver disease...
The FDA has approved another T-cell engager therapy for patients with heavily pretreated multiple myeloma The U.S. Food and...
The FDA approved a combination of the PARP inhibitor niraparib with a hormone therapy agent for certain patients with...
The FDA granted full approval to pralsetinib as a treatment for certain patients with non-small cell lung cancer The...
Certain patients with advanced multiple myeloma may be eligible for treatment with a new immunotherapy drug. The U.S. Food...
The FDA approved a combination of trifluridine, tipiracil, and bevacizumab for the treatment of heavily pretreated metastatic colorectal cancer. ...